An Executive Order has been issued mandating accelerated research into psychedelic therapies through partnerships between various bodies.
19 reports, 10 independent
Updated Sep 14
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 19
- Developments
- 5
- Repetition
- 84%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
An Executive Order has been issued mandating accelerated research into psychedelic therapies through partnerships between various bodies.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.FDA and DEA are collaborating to accelerate investigational treatment pathways for psychedelic drugs.1 source
- Cohoba promotes the therapeutic use of mind-altering substances as an executive order pushes for expedited drug approvals.Sub-event
- Trump wanted FDA approval for psychedelic therapies. Heidi Overton advised on policy regarding the executive order, which led to team submissions to the Domestic Policy Council.Sub-event
Executive order accelerates review of psychedelic treatments.1 source
Executive Order accelerates psychedelic therapy research involving FDA, HHS, and the administration.1 source
Keep exploring
The entities involved
- FDA
-
Department of Health & Human Services
government department in the state of Victoria, Australia
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Coverage
Newest first; wire copies grouped- hot96.com
- whtc.com
- kdhnews.com
- military.com
- billboard.com
- timescall.com
- prnewswire.com
- stripes.com
- finanznachrichten.de
- navytimes.com
- military.com